Dare Bioscience annual operating margin
2016
2022
2023
2024
2025
Dare Bioscience Operating Margin Growth & History (DARE)
Dare Bioscience's operating margin was −1,315.51% for fiscal 2025.
View full Dare Bioscience company overviewDare Bioscience annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,315.51% | +238376.69 pp |
| 2024 | 2024-12-31 | −239,692.20% | −238590.31 pp |
| 2023 | 2023-12-31 | −1,101.89% | −788.04 pp |
| 2022 | 2022-12-31 | −313.85% | −231.53 pp |
| 2016 | 2016-12-31 | −82.32% | — |
Dare Bioscience quarterly operating margin
Q1.17
Q2.17
Q2.22
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q1.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −1,582.53% | +16434.21 pp |
| Q1 2026 | 2026-03-31 | −1,967.07% | +9261.61 pp |
| Q4 2025 | 2025-12-31 | −143.72% | +32655.39 pp |
| Q3 2025 | 2025-09-30 | −162,340.76% | −97596.91 pp |
| Q1 2025 | 2025-03-31 | −18,016.75% | −17730.70 pp |
| Q3 2024 | 2024-09-30 | −11,228.68% | −10389.04 pp |
| Q2 2024 | 2024-06-30 | −32,799.12% | −32802.96 pp |
| Q1 2024 | 2024-03-31 | −64,743.85% | −64669.14 pp |
| Q4 2023 | 2023-12-31 | −286.05% | −266.88 pp |
| Q3 2023 | 2023-09-30 | −839.64% | — |
| Q2 2022 | 2022-06-30 | 3.84% | — |
| Q2 2017 | 2017-06-30 | −74.71% | — |
| Q1 2017 | 2017-03-31 | −19.17% | — |
Dare Bioscience operating margin trends
Across the available reported history, Dare Bioscience's operating margin increased from −239,692.20% to −1,315.51%, a change of +238376.69 percentage points. The latest reported quarter, Q2 2026, shows −1,582.53%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dare Bioscience filings at SEC.gov ↗